There are no new cases of COVID-19 in South East Zone 4, which includes Estevan, according to the daily report from the Saskatchewan Health Authority.
After one recovery, the number of COVID-19 cases in Zone 4 is at two.
There is one new cases of COVID-19 to report in the South East region on June 21, located in Weyburn’s Zone 3.
There are 48 new cases of COVID-19 to report in Saskatchewan on June 21, bringing the provincial total to 48,490 cases.
The other new cases are located in the following zones: Far North West, 5; Far North East, 1; North West, 3; North Central, 10; Saskatoon, 6; Central West, 2; Regina, 15; and South Central, 3.
Two new deaths were reported today, both in the 80+ age group. One death was reported in the North Central Zone. The other death was reported in the North West zone.
Seventy-nine more people have recovered, bringing the total number of recoveries to 47,214. Two of the new recoveries are from the South East region.
A total of 711 cases are considered active, including 33 from the South East.
There are 76 people in hospital. This is the lowest number of hospitalizations since November 18, 2020. Sixty-five are receiving inpatient care and 11 people are in intensive care. For the fourth straight day, nobody is in hospital with COVID-19 in the South East region.
The seven-day average of new COVID-19 case number is 69.
There were 1,518 COVID-19 tests processed in Saskatchewan on June 20, including 121 in the South East.
Effective today, vaccine reporting numbers have returned to a 48-hour reporting period and thus will appear lower today. The vaccine administration reporting timeline was adjusted to a 24-hour period Friday, Saturday and Sunday in order to provide the most up to date information to support a decision on the ability to move to Step 3 of the Re-Open Roadmap.
As of end of day Saturday, June 19, there were an additional 961 vaccinations administered in Saskatchewan, bringing the total number of vaccines administered in the province to 998,779.
Eighty per cent of those over the age of 40+ have received their first dose. Seventy-four per cent of those 30+ have received their first dose. Seventy per cent of those 18+ have received their first dose, while sixty-nine per cent of those 12+ have also received their first dose.
